Navigation Links
Anti-allergy vaccine based on 'hygiene hypothesis'

A new vaccine has been developed that could obliterate common allergies like asthma, pollen and hayfever that afflict millions of people.//

The ‘hygiene hypothesis’ suggests that allergies may occur indirectly due to too much cleanliness as it deprives the immune system of a proper training against germs that have lived with humans for millions of years. As a result, the body begins to produce reactions against harmless substances like grass pollen.

This theory was exploited by a Swiss-based Cytos Biotechnology company to develop an anti-allergy drug that makes the immune system to focus on mycobacteria. This drug called CYT003 – QbG10 activates the immune system to attack potentially larger threats like mycobacteria, a group of bacteria found in soil and water that are come across rarely these days due to modern cleanliness. In this manner, the immune system is deceived and made to forget the allergens and look for bigger threats.

A study was conducted on 10 people with hay fever. It was found that there was a 100-fold reduction in the patient’s sensitivity to grass pollen after a 6-weeks course of injections.
A previous study reveals drug’s efficacy against house dust mite allergy. The patients were without any symptoms for one year when the drug was given along with doses of the allergen.
The researchers used a DNA strand that imitates mycobacteria’s genetic material. This DNA is packed into a fake virus particle and delivered into the body. This is taken up by the immune system.

The company is currently testing the drug in over 100 people with hay fever, house dust mite allergy, and allergic dermatitis. The results are expected to be out in the first half of 2007.

'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: